What Is Geron Corporation (GERN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Geron Corporation's intrinsic value is estimated at $0.85. Trading at its current price of $1.42, the valuation engine raises significant caution: 8 of 9 models flag downside risk, projecting an average implied return of -40.3%. The most optimistic model, Sentiment SOTP, places fair value at $1.48 (+3.9%), while Dynamic NAV — the most conservative — estimates $0.37 (-73.7%). This +77.6% gap reflects genuine analytical uncertainty about Geron Corporation's intrinsic worth.
What Do the Models Say About GERN?
9 of 13 models are currently active for GERN. Of these, 1 model suggests upside while 8 models suggest overvaluation. The Bayesian DCF estimates GERN's intrinsic value at $0.40, implying -72.1% downside from the current price. See which stocks rank higher →
How Does GERN Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, GERN ranks #244 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to pharmaceutical industry businesses. For Geron Corporation, metrics like revenue per drug provide important context that general-purpose valuation models may underweight.
Is GERN a Value Trap?
CirclFi's Value Trap algorithm assigns GERN a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Geron Corporation. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Geron Corporation scores 4.8 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +77.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GERN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GERN's 9 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad